Cleveland BioLabs, Inc. (Nasdaq: CBLI) and its subsidiary, Incuron, LLC, today announced the results of new studies demonstrating potentially curative ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE